Page last updated: 2024-09-03

1-(4-methoxyphenyl)pyridinium and amphetamine

1-(4-methoxyphenyl)pyridinium has been researched along with amphetamine in 1 studies

Compound Research Comparison

Studies
(1-(4-methoxyphenyl)pyridinium)
Trials
(1-(4-methoxyphenyl)pyridinium)
Recent Studies (post-2010)
(1-(4-methoxyphenyl)pyridinium)
Studies
(amphetamine)
Trials
(amphetamine)
Recent Studies (post-2010) (amphetamine)
550113,0713291,977

Protein Interaction Comparison

ProteinTaxonomy1-(4-methoxyphenyl)pyridinium (IC50)amphetamine (IC50)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)0.96
Cytochrome P450 2A6Homo sapiens (human)3.5
Cytochrome P450 2A5Mus musculus (house mouse)2.85
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.96
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.96

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Del Zompo, M; Gessa, GL; Piccardi, MP; Quartu, M; Ruiu, S; Vaccari, A1

Other Studies

1 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and amphetamine

ArticleYear
Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
    British journal of pharmacology, 1993, Volume: 109, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Biomarkers; Brain; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Male; Mice; Microscopy, Electron; MPTP Poisoning; Nervous System Diseases; Pyridinium Compounds; Synaptic Vesicles; Tetrabenazine

1993